Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


11.03.2019

1 Acta Neuropathol
1 AJNR Am J Neuroradiol
1 Clin Ther
2 J Neuroimmunol
3 J Neurol Neurosurg Psychiatry
1 Lancet Neurol
1 Mult Scler
1 Neurology
1 Neurosci Lett


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. BRAMBILLA R
    The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Acta Neuropathol. 2019 Mar 7. pii: 10.1007/s00401-019-01980.
    PubMed     Text format     Abstract available


    AJNR Am J Neuroradiol

  2. DO AMARAL LLF, Fragoso DC, Nunes RH, Littig IA, et al
    Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences.
    AJNR Am J Neuroradiol. 2019 Mar 7. pii: ajnr.A5997. doi: 10.3174/ajnr.A5997.
    PubMed     Text format     Abstract available


    Clin Ther

  3. VERMERSCH P, Martinelli V, Pfleger C, Rieckmann P, et al
    Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis.
    Clin Ther. 2019;41:249-260.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  4. DA SILVA BERNARDES M, Antao Paiva CL, Ribeiro Paradela E, Papais Alvarenga M, et al
    Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease?
    J Neuroimmunol. 2019;330:74-80.
    PubMed     Text format     Abstract available

  5. ZAROBKIEWICZ MK, Kowalska W, Rolinski J, Bojarska-Junak AA, et al
    gammadelta T lymphocytes in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2019;330:67-73.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  6. RAGONESE P
    Food of the gods for the treatment of multiple sclerosis related fatigue?
    J Neurol Neurosurg Psychiatry. 2019 Mar 4. pii: jnnp-2018-319926.
    PubMed     Text format    

  7. CRIELAARD L, Kavaliunas A, Ramanujam R, Olsson T, et al
    Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study.
    J Neurol Neurosurg Psychiatry. 2019 Mar 1. pii: jnnp-2018-319913.
    PubMed     Text format     Abstract available

  8. COE S, Cossington J, Collett J, Soundy A, et al
    A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2019 Mar 4. pii: jnnp-2018-319496.
    PubMed     Text format     Abstract available


    Lancet Neurol

  9. WILLIAMS R
    David Hafler: a ceaseless drive to solve multiple sclerosis.
    Lancet Neurol. 2019 Mar 4. pii: S1474-4422(19)30073.
    PubMed     Text format    


    Mult Scler

  10. STRAUDI S, Manfredini F, Lamberti N, Martinuzzi C, et al
    Robot-assisted gait training is not superior to intensive overground walking in multiple sclerosis with severe disability (the RAGTIME study): A randomized controlled trial.
    Mult Scler. 2019 Mar 4:1352458519833901. doi: 10.1177/1352458519833901.
    PubMed     Text format     Abstract available


    Neurology

  11. ZULUAGA MI, Otero-Romero S, Rovira A, Perez-Hoyos S, et al
    Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis.
    Neurology. 2019 Mar 1. pii: WNL.0000000000007178.
    PubMed     Text format     Abstract available


    Neurosci Lett

  12. MIFFLIN K, Baker GB, Kerr BJ
    Effect of voluntary wheel running on neuroactive steroid levels in murine experimental autoimmune encephalomyelitis.
    Neurosci Lett. 2018;685:150-154.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: